NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 124 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,108,671 | -65.8% | 3,839,879 | -17.1% | 0.00% | – |
| Q2 2023 | $11,999,484 | -28.4% | 4,633,005 | +12.8% | 0.00% | – |
| Q1 2023 | $16,753,060 | -19.8% | 4,106,142 | -1.3% | 0.00% | -100.0% |
| Q4 2022 | $20,882,006 | -60.7% | 4,159,762 | +2.3% | 0.00% | -50.0% |
| Q3 2022 | $53,192,000 | +7.1% | 4,066,577 | +5.0% | 0.00% | 0.0% |
| Q2 2022 | $49,649,000 | +14.6% | 3,872,749 | +36.4% | 0.00% | +100.0% |
| Q1 2022 | $43,306,000 | -12.1% | 2,839,674 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $49,250,000 | -4.2% | 2,780,791 | +13.7% | 0.00% | 0.0% |
| Q3 2021 | $51,391,000 | +13.3% | 2,444,832 | +6.3% | 0.00% | 0.0% |
| Q2 2021 | $45,343,000 | -43.6% | 2,299,355 | -16.8% | 0.00% | -50.0% |
| Q1 2021 | $80,365,000 | +5.0% | 2,764,580 | +9.5% | 0.00% | 0.0% |
| Q4 2020 | $76,513,000 | +96.7% | 2,525,616 | +3.3% | 0.00% | +100.0% |
| Q3 2020 | $38,891,000 | -13.8% | 2,444,439 | +7.0% | 0.00% | -50.0% |
| Q2 2020 | $45,116,000 | +62.5% | 2,285,474 | +1.5% | 0.00% | +100.0% |
| Q1 2020 | $27,762,000 | -35.0% | 2,251,506 | -2.5% | 0.00% | -50.0% |
| Q4 2019 | $42,679,000 | +371.0% | 2,308,286 | +252.8% | 0.00% | – |
| Q3 2019 | $9,062,000 | +93.0% | 654,349 | +104.0% | 0.00% | – |
| Q2 2019 | $4,696,000 | – | 320,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |